“…Enhances IL-1 mediated IL-6 in RA synoviocytes as well as TNF-induced synthesis of IL-1, IL-6, IL-8 [15,16] IL-17 additative/synergistic effect with TNF or IL-1 [33] IL-17 synergize with IL-1, TNF [10,20,32] IL-17 effect is TNF dependent under naïve conditions, but TNF independent under arthritis conditions [38] IL-17 effect is IL-1 independent in experimental arthritis [8,37] IL-17 in bone damage IL-17 induces RANKL in cultures of osteoblasts [13] IL-17 induces bone damage in naïve mice, aggravates bone erosion in CIA [44] Synergy between IL-17 and TNF [20,25,32] IL-17-induced bone erosion is RANKL mediated [44] IL-17 in cartilage damage IL-17 induces NO [34], metalloproteinases in synoviocytes and chondrocytes [17][18][19] Inducer of NO and MMPs and inhibition of PG synthesis [26], aggravates cartilage erosion in CIA [8,9] Synergy between IL-17 and TNF [29] IL-1 independent role of IL-17 in cartilage damage [8,19,28] Th17 IL-17-producing cells in the synovium of RA patients (Th0/Th1 but not Th2) [14] IL-17-producing cells and Th17 in CIA and AIA arthritis models [55,60,70] effects of IL-17 on matrix degradation and synthesis were not dependent on IL-1 production by chondrocytes and IL-1Ra did not block IL-17-induced matrix release nor prevented inhibition of matrix synthesis in vitro using porcine articular cartilage explants [28]. On the other hand, the IL-17 induced production of prostaglandin E2 (PGE2) and nitric oxide (NO) by cartilage explants is LIF-dependent [28,36].…”